Chapter 9: Indications for the treatment of primary hyperparathyroidism

The choice of therapeutic method for the management of primary hyperparathyroidism depends on the severity of the disease and its complications at the time of diagnosis, the specific situation of each patient and his/her natural history, and assessment of the risk/benefit ratio for each method (surgery, local destruction or drugs). This chapter summarizes the indications for the treatment of primary hyperparathyroidism, based on the international literature available as of December 31st, 2023.

Published by Annales d'endocrinologie, 2025. The guideline itself is at the source linked here.

doi.org/10.1016/j.ando.2025.101698